Coronavirus Update: No Mortality Gains From Remdesivir In WHO Trial, Gilead Questions Results
Trial Involved 11,000 Patients
Plus Sanofi and Translate Bio release preclinical data from their COVID-19 vaccine candidate, another entrant to the now crowded mRNA vaccine field.
